Marcus‐Alexander Wörns

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text

Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany

Christian Labenz, Yvonne Huber, Eva Kalliga et al. · Alimentary Pharmacology & Therapeutics · 2018 · 102 citations · Full text

Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients

Christian Labenz, Justine Baron, Gerrit Toenges et al. · Alimentary Pharmacology & Therapeutics · 2018 · 93 citations · Full text

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

Massimo Iavarone, Federica Invernizzi, Carolin Czauderna et al. · American Journal of Transplantation · 2019 · 85 citations · Full text